Senior Manager, Clinical Supply Integration

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. With our transformation into a fully integrated oncology company well underway, it’s an exciting time to be part of Team Olema.

Our lead product candidate, palazestrant, is a novel, orally available complete estrogen receptor antagonist (CERAN) and selective estrogen receptor degrader (SERD) currently in two pivotal Phase 3 clinical trials. We expect top-line data from OPERA-01, our ongoing Phase 3 trial of palazestrant as a monotherapy in patients with second- or third-line ER+/HER2- metastatic breast cancer (MBC), in Q1 2027 which, if positive, could lead to our first potential approval and commercial launch in 2028. OPERA-02, our Phase 3 trial of palazestrant in combination with ribociblib in patients with frontline ER+/HER2- MBC, is enrolling patients. Together with its mechanism of action, pharmacokinetic properties, and the potential to demonstrate activity in both ESR1 wild-type and mutant tumors, palazestrant could transform the metastatic breast cancer treatment paradigm and provide access to a $15 billion global market opportunity.

Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor with the potential to generate further value and meaningfully impact the metastatic breast cancer treatment landscape – particularly in combination with palazestrant. We recently presented encouraging Phase 1 monotherapy data from this program across multiple solid tumor types, are advancing patient enrollment in the ongoing combination arms in MBC, and expect to initiate a Phase 1 study of OP-3136 in combination with Bayer’s darolutamide in metastatic castration-resistant prostate cancer by the end of this year.

Aspiring to transform the metastatic treatment paradigm is an ambitious endeavor that requires a resolute approach to developing better therapies and passionate colleagues dedicated to helping the patients we serve feel better, longer. Team Olema possesses a deep commitment to a shared purpose, the sustained pursuit of excellence, cultivating the courage required to advance our programs, the drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. We are a small group of nimble self-starters who bring consistency in our quest for the extraordinary every single day.

If you’re ready to be part of a tenacious, courageous, agile, and growing team, join us in making a profound impact, together – for our patients, for your career, and for what’s beyond.

About the Role Senior Manager, Clinical Supply Integration

As the Senior Manager, Clinical Supply Integration reporting to the Vice President, Clinical Supply Chain, you will oversee the end-to-end flow of investigational medicinal products (IMPs), from manufacturing through packaging and labeling, QP release, logistics, clinical depots, and trial sites. Serving as the central point of coordination across external providers and internal study teams, you will ensure plans are executable, lead times and dependencies are visible, risks are identified and addressed early, and medicines reach patients safely and on time. In addition you will partner closely with Clinical Operations, CMC, Quality, Regulatory, Finance, and external vendors to support global clinical programs as Olema continues to advance its pipeline.

This role is based out of our San Francisco or Boston office and will require 10-15% domestic or international travel.

Your work will primarily encompass:

• Lead coordination of clinical supply activities across global CDMOs in the US, EU, UK, APAC, and LATAM, managing multiple timelines, dependencies and linked deliverables
• Oversee project logistics for packaging and labeling, procurement, and manufacturing runs, aligning activities across Clinical Supply, Clinical Operations, Quality, Regulatory, and CMC
• Partner with internal supply chain team and external vendors to ensure timely execution and appropriate identification and escalation of issues
• Maintain supply timelines for all clinical programs, including supply protocols, procedures, systems and documentation management
• Partner with the Vice President, Supply Chain and Finance to support and manage departmental budgets, monitor project progress, and ensure packaging, labeling, and global distribution are properly planned and executed
• Identify operational gaps and drive cross-functional continuous improvement initiatives, implementing SOPs, lessons learned, and best practices to strengthen and scale clinical supply operations as the portfolio grows

Ideal Candidate Profile

A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge , experience , and attributes for this role.

Knowledge:

• Bachelor's degree is required; master's degree is preferred
• Strong understanding of end-to-end global clinical supply operations
• Working knowledge of GMP, GDP, Quality, Clinical Operations, and regulatory requirements
• Familiarity with clinical supply, QMS, planning, project management, and data/reporting systems

Experience:

• Minimum of 8+ years of progressive clinical supply experience with a Bachelor’s degree, or 6+ years with a Master’s degree, within the biotechnology or pharmaceutical industry; experience supporting complex global and/or late-stage studies preferred
• Demonstrated experience coordinating end-to-end clinical supply activities across manufacturing, packaging and labeling, release
• Previous exposure to inventory, demand, expiry, logistics, and distribution preferred
• Strong project management and data reconciliation skills, with demonstrated ability to investigate discrepancies and drive issues through resolution
• Strong vendor management and governance experience, including performance monitoring, issue escalation, and resolution
• Oncology clinical trial experience preferred

Attributes:

• Clear, concise communicator who can influence without direct authority
• Strong analytical judgment, problem-solving, and risk-management skills, with the ability to identify issues early and escalate appropriately
• Highly organized and capable of managing multiple complex timelines, priorities, and dependencies simultaneously
• Strong sense of ownership and accountability, with consistent follow-through from planning through execution
• Collaborative and effective at building productive relationships across internal teams and external partners
• Hands-on and operationally minded, proactive, pragmatic, and committed to continuous improvement and operational excellence
• Strong commitment to patients, teamwork, quality, and results

The base pay range for this position is expected to be $150,000 - $160,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, skills and capabilities, and experience. The total compensation package for this position also includes equity, bonus, and benefits.

#LI-MT1

Important Information

We provide equal opportunity to all employees and applicants for employment and believe that great ideas and discoveries come from a mix of expertise, background, and experience. Olema is building a culture where the value of difference is celebrated.

We offer a competitive compensation and benefits package , seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants.

Please note: Olema doesn’t accept agency resumes and is not responsible for any fees related to unsolicited resumes. Thank you.

Fraud Alert : We are aware of employment scams where individuals pose as representatives of Olema Oncology and make false use of our company name to defraud job seekers. To protect yourself, please note that Olema’s official email addresses end in @olema.com. Our official corporate website is olema.com ; our careers page is olema.com/careers ; our LinkedIn page is linkedin.com/company/olema-oncology . Please visit these links for official information from Olema. Communication from any other variant is fraudulent. Olema does not conduct interviews via text message/messaging platforms, will not ask you to download anything as part of your interview, will never request any form of payment, provide upfront payments of any kind, and does not make job offers without an in-person interview.